
Anika Therapeutics
Anika Therapeutics | Global Medical Technologies | Pain Management, Tissue Regeneration, Wound Healing.
Market cap
$132m
Enterprise value
$104m
Share price
$9.23 ANIK
Recent deals
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
* | N/A | Post IPO Equity | |
Total Funding | 000k |
USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 13 % | 6 % | 7 % | (28 %) | (7 %) | 5 % | 8 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (27 %) | (12 %) | 31 % | 3 % | 2 % | 5 % | 9 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 3 % | (10 %) | (50 %) | (47 %) | (14 %) | (8 %) | 2 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 18 % | 18 % | 20 % | 21 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Anika Therapeutics
Edit
ACQUISITION by Anika Therapeutics Dec 2009

ACQUISITION by Anika Therapeutics Feb 2020